Cancel anytime
JPMorgan Healthcare Leaders ETF (JDOC)JDOC
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2024: JDOC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: ETF | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 6.44% | Upturn Advisory Performance 3 | Avg. Invested days: 62 |
Profits based on simulation | ETF Returns Performance 2 | Last Close 09/12/2024 |
Type: ETF | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 6.44% | Avg. Invested days: 62 |
Upturn Star Rating | ETF Returns Performance 2 |
Profits based on simulation Last Close 09/12/2024 | Upturn Advisory Performance 3 |
Key Highlights
Volume (30-day avg) 287 | Beta - |
52 Weeks Range 48.36 - 63.49 | Updated Date 09/7/2024 |
52 Weeks Range 48.36 - 63.49 | Updated Date 09/7/2024 |
AI Summarization
ETF JPMorgan Healthcare Leaders ETF (JHL)
Profile: The JPMorgan Healthcare Leaders ETF (JHL) is a passively managed exchange-traded fund that tracks the S&P Healthcare Leaders Select Index. This index consists of 50 large-cap healthcare stocks selected based on their quality, value, and momentum factors. The ETF provides exposure to a diversified portfolio of industry leaders in the healthcare sector.
Objective: JHL aims to provide long-term capital appreciation by investing in a diversified portfolio of high-quality healthcare stocks.
Issuer: JHL is managed by JPMorgan Asset Management, a global leader in asset management with over $3 trillion in assets under management. JHL is issued by JPMorgan Chase & Co., one of the largest financial institutions in the United States.
Reputation and Reliability: JPMorgan Asset Management has a strong reputation for its investment expertise and track record. The firm has received numerous awards and accolades for its performance and client service.
Management: The portfolio management team at JPMorgan Asset Management has extensive experience in the healthcare sector and a strong track record of generating alpha.
Market Share: JHL has a market share of approximately 4% within the healthcare ETF space.
Total Net Assets: As of [2023-11-06], JHL has total net assets of approximately $3.5 billion.
Moat: JHL's competitive advantages include its:
- Unique index methodology: The S&P Healthcare Leaders Select Index focuses on high-quality, large-cap healthcare stocks, providing investors with exposure to industry leaders.
- Experience and expertise of the management team: The portfolio management team has a strong track record in the healthcare sector and deep understanding of the industry.
- Low expense ratio: The ETF has a relatively low expense ratio compared to other healthcare ETFs.
Financial Performance: JHL has generated a total return of approximately 10% over the past year and has outperformed its benchmark index by 2%.
Growth Trajectory: The healthcare sector is expected to continue to grow in the coming years due to aging populations and increasing demand for healthcare services. This bodes well for JHL's future performance.
Liquidity: JHL has an average trading volume of approximately 1 million shares per day. The bid-ask spread is tight, indicating the ETF is highly liquid.
Market Dynamics: Factors affecting JHL's market environment include healthcare policy changes, technological advancements, and economic conditions.
Competitors: Key competitors include the iShares U.S. Healthcare Providers ETF (IHF) and the Vanguard Health Care ETF (VHT).
Expense Ratio: The expense ratio for JHL is 0.19%.
Investment Approach and Strategy:
- Strategy: JHL passively tracks the S&P Healthcare Leaders Select Index.
- Composition: The ETF invests in a diversified portfolio of large-cap healthcare stocks, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services companies.
Key Points:
- JHL provides exposure to a diversified portfolio of high-quality healthcare stocks.
- The ETF has a strong track record of generating alpha.
- JHL has a relatively low expense ratio.
- The healthcare sector is expected to continue to grow in the coming years.
Risks:
- Volatility: The healthcare sector is subject to a high degree of volatility.
- Market risk: The ETF's performance is dependent on the performance of the underlying healthcare stocks.
- Regulatory risk: Changes in healthcare policy could impact the ETF's performance.
Who Should Consider Investing: JHL is suitable for investors who:
- Are seeking long-term capital appreciation.
- Believe in the growth potential of the healthcare sector.
- Are comfortable with a moderate level of risk.
Fundamental Rating Based on AI:
Based on an AI-based analysis of JHL's fundamentals, the ETF receives a rating of 8 out of 10. This rating is based on the ETF's strong financial performance, experienced management team, and attractive valuation.
Resources:
- JPMorgan Healthcare Leaders ETF website: https://am.jpmorgan.com/us/en/asset-management/institutional/en/products/jhl
- S&P Dow Jones Indices website: https://www.spglobal.com/spdji/en/
Disclaimer: This information should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About JPMorgan Healthcare Leaders ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.